News tagged: Institutional Analysis

Tag: Institutional Analysis

Gold’s $5,000 Scenario Gains Traction as Momentum and Global Risks Build

Commodities

January 13, 2026

Gold’s $5,000 Scenario Gains Traction as Momentum and Global Risks Build

Spot gold has more than a 30% probability of reaching $5,000 per troy ounce this year, driven by strong price momentum and intensifying geopolitica...

Gold Breaks Above $4,600/oz for the First Time

Commodities

January 12, 2026

Gold Breaks Above $4,600/oz for the First Time

Gold prices surged to historic highs on Monday, breaking through $4,600 per ounce for the first time ever as investors rushed into safe-haven asset...

Oil Prices Rise for Second Straight Session as Geopolitical Risks Outweigh Supply Concerns

Commodities

January 10, 2026

Oil Prices Rise for Second Straight Session as Geopolitical Risks Outweigh Supply Concerns

Crude oil futures posted back-to-back gains and finished the week higher, as renewed geopolitical tensions involving Iran and the Russia–Ukra...

Asian Markets Drift Lower as Investors Brace for U.S. Jobs Data and Supreme Court Tariff Ruling

Stock Market

January 9, 2026

Asian Markets Drift Lower as Investors Brace for U.S. Jobs Data and Supreme Court Tariff Ruling

Asian stocks edged lower on Friday while the U.S. dollar held firm, as investors remained cautious ahead of two key market-moving events: the U.S. ...

Gold Slips as Investors Weigh US Data and Rising Geopolitical Risks

Commodities

January 8, 2026

Gold Slips as Investors Weigh US Data and Rising Geopolitical Risks

Gold prices eased to around $4,440 per ounce on Thursday, extending losses from the prior session as investors digested mixed U.S. economic signals...

Market Insights

January 6, 2026

Why Silver’s Set-Up Looks Explosive

Silver is no longer “gold’s understudy.” Its role in the global economy has undergone a complete transformation, driven by the el...

Zenas BioPharma Shares Plunge 55% Despite ‘Positive’ Phase 3 Trial Results

Stock Market

January 6, 2026

Zenas BioPharma Shares Plunge 55% Despite ‘Positive’ Phase 3 Trial Results

Zenas BioPharma (ZBIO) stunned investors on Monday after its shares plunged 55%, even as the company reported what it described as “positive&...

Comex Gold Signals Uptrend Resumption as Bulls Regain Control

Commodities

January 6, 2026

Comex Gold Signals Uptrend Resumption as Bulls Regain Control

Comex gold futures appear to be resuming their upward trend, supported by strengthening bullish momentum on the daily chart, according to RHB Retai...